Insys To Pay $225M To End DOJ's Opioid Scheme Probe

By Chris Villani · June 5, 2019, 8:18 PM EDT

Insys Therapeutics has agreed to a $225 million global settlement to end criminal and civil investigations by the federal government tied to allegations the pharmaceutical company bribed doctors to prescribe a...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

United States of America et al v. INSYS Therapeutic Inc

Case Number

Court

California Central

Nature of Suit

Other Statutes: False Claims Act

Date Filed

August 12, 2013

Recent Articles By Chris

May 23, 2025
Trump Admin Must Restore 'Censored' Harvard Docs' Articles
April 21, 2025
Harvard Sues Trump Admin Over $2B Funding Freeze
March 12, 2025
Harvard Docs Say Gov't Censored Articles With Gender Terms
February 13, 2025
Small But Mighty Busy: 1st Circ. A Hub For Anti-Trump Suits
November 13, 2024
Mass. AG Ready To Reprise Office's Role As Trump Foil
August 12, 2024
Big Tobacco To Pay $600M In 'Historic' Mass. Deal
July 23, 2024
'Surface Water' Stumps Mass. Justices In Loss For Insurers
July 12, 2024
Feds Say Fake Gunshot Wounds Part Of $1M Fraud Scheme
March 01, 2024
GSK, Shook Hardy Can Recover Costs After Zofran MDL Win
February 26, 2024
Teva Tells 1st Circ. Feds Must Clear High Bar In FCA Case